Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines
Open accessThe DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.
Abstract
Pain is common in cancer patients, particularly in the advanced stage of disease when the prevalence is estimated to be more than 70% [1], contributing to poor physical and emotional well-being. The most comprehensive systematic review indicates pain prevalence ranging from 33% in patients after curative treatment, to 59% in patients on anticancer treatment and to 64% in patients with metastatic, advanced or terminal disease [2]. Pain has a high prevalence earlier in disease in specific cancer types such as pancreatic (44%) and head and neck cancer (40%) [3].
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 2 The assessment of BTcP. BTcP, breakthrough cancer pain. Reprinted with permission from [116].](https://figures.cochat.ai/paper-figures/ca72788a69f549f1926fbf99429f0118/management-of-cancer-pain-in-adult-patients-esmo-clinical-practice-guidelines-figure-2.png)







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and the recent ESMO guidelines106 are difficult to follow in those countries where the majority of patients experiencing cancer pain live.”
From 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) (2020) · cites this paper as [106]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Opioid Complications and Side Effects
Benyamin, R. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/s105 · Cited by 2,245
Pain and Its Treatment in Outpatients with Metastatic Cancer
Cleeland, C. S., Gonin, R., Hatfield, A. K., Edmonson, J. H., Blum, R. H., Stewart, J. A., & Pandya, K. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300902 · Cited by 2,019
Fizazi, K., Carducci, M., Smith, M., Damião, R., Brown, J., Karsh, L., Milecki, P., Shore, N., Rader, M., Wang, H., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62344-6 · Cited by 1,971
Prevalence of pain in patients with cancer: a systematic review of the past 40 years
van den Beuken-van Everdingen, M. H. J., de Rijke, J. M., Kessels, A. G., Schouten, H. C., van Kleef, M., & Patijn, J. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm056 · Cited by 1,923
Stopeck, A. T., Lipton, A., Body, J.-J., Steger, G. G., Tonkin, K., de Boer, R. H., Lichinitser, M., Fujiwara, Y., Yardley, D. A., Viniegra, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.7101 · Cited by 1,597
Knaul, F. M., Farmer, P. E., Krakauer, E. L., De Lima, L., Bhadelia, A., Jiang Kwete, X., Arreola-Ornelas, H., Gómez-Dantés, O., Rodriguez, N. M., Alleyne, G. A. O., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32513-8 · Cited by 1,456
Caraceni, A., Hanks, G., Kaasa, S., Bennett, M. I., Brunelli, C., Cherny, N., Dale, O., De Conno, F., Fallon, M., Hanna, M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70040-2 · Cited by 1,243
Self-citation
Cited by
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
Cardoso, F., Costa, A., Senkus, E., Aapro, M., André, F., Barrios, C. H., Bergh, J., Bhattacharyya, G., Biganzoli, L., Cardoso, M. J., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdw544 · Cited by 2,033
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
Cardoso, F., Paluch-Shimon, S., Senkus, E., Curigliano, G., Aapro, M. S., André, F., Barrios, C. H., Bergh, J., Bhattacharyya, G. S., Biganzoli, L., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.09.010 · Cited by 1,369
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Conroy, T., Pfeiffer, P., Vilgrain, V., Lamarca, A., Seufferlein, T., O’Reilly, E. M., Hackert, T., Golan, T., Prager, G., Haustermans, K., et al. (2023) · Annals of Oncology · doi:10.1016/j.annonc.2023.08.009 · Cited by 610
Snijders, R., Brom, L., Theunissen, M., & van den Beuken-van Everdingen, M. (2023) · Cancers · doi:10.3390/cancers15030591 · Cited by 445
“The observed decrease in cancer pain prevalence and pain severity may also be positively impacted by raised awareness and knowledge of healthcare professionals about cancer pain treatment and the publication of new pain therapy guidelines [26,27].”
The positive role of traditional Chinese medicine as an adjunctive therapy for cancer
Zhang, X., Qiu, H., Li, C., Cai, P., & Qi, F. (2021) · BioScience Trends · doi:10.5582/bst.2021.01318 · Cited by 408
Henson, L. A., Maddocks, M., Evans, C., Davidson, M., Hicks, S., & Higginson, I. J. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.00470 · Cited by 367
“Two recent Cochrane reviews found only weak evidence to support their use,(55,56) and some authors have suggested bypassing step two of the WHO analgesic ladder and proceeding directly from step one to step three.(57,58) Opioids, specifically morphine, remain the first-choice analgesic for moderate to severe cancer-re…”
BackgroundInfluentialJordan, B., Margulies, A., Cardoso, F., Cavaletti, G., Haugnes, H. S., Jahn, P., Le Rhun, E., Preusser, M., Scotté, F., Taphoorn, M. J. B., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.07.003 · Cited by 338
Peris, K., Fargnoli, M. C., Kaufmann, R., Arenberger, P., Bastholt, L., Seguin, N. B., Bataille, V., Brochez, L., del Marmol, V., Dummer, R., et al. (2023) · European Journal of Cancer · doi:10.1016/j.ejca.2023.113254 · Cited by 308
Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline
Paice, J. A., Bohlke, K., Barton, D., Craig, D. S., El-Jawahri, A., Hershman, D. L., Kong, L. R., Kurita, G. P., LeBlanc, T. W., Mercadante, S., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.02198 · Cited by 304
Biganzoli, L., Battisti, N. M. L., Wildiers, H., McCartney, A., Colloca, G., Kunkler, I. H., Cardoso, M.-J., Cheung, K.-L., de Glas, N. A., Trimboli, R. M., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30741-5 · Cited by 298
A systematic review of rehabilitation and exercise recommendations in oncology guidelines
Stout, N. L., Santa Mina, D., Lyons, K. D., Robb, K., & Silver, J. K. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21639 · Cited by 286
Bone Pain in Cancer Patients: Mechanisms and Current Treatment
Zajączkowska, R., Kocot-Kępska, M., Leppert, W., & Wordliczek, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236047 · Cited by 262
Cancer Pain Assessment and Classification
Caraceni, A., & Shkodra, M. (2019) · Cancers · doi:10.3390/cancers11040510 · Cited by 256
Cancer Pain Management: A Narrative Review of Current Concepts, Strategies, and Techniques
Mestdagh, F., Steyaert, A., & Lavand’homme, P. (2023) · Current Oncology · doi:10.3390/curroncol30070500 · Cited by 221
Care of the adult cancer patient at the end of life: ESMO Clinical Practice Guidelines
Crawford, G. B., Dzierżanowski, T., Hauser, K., Larkin, P., Luque-Blanco, A. I., Murphy, I., Puchalski, C. M., & Ripamonti, C. I. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100225 · Cited by 209
“As death approaches, ongoing pain management is usually required, with morphine and other opioids being the mainstay of treatment.(34) Nonpharmacological management that promotes comfort measures and psychological support may be beneficial.”
BackgroundSelf-citationParacetamol: A Review of Guideline Recommendations
Freo, U., Ruocco, C., Valerio, A., Scagnol, I., & Nisoli, E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153420 · Cited by 208
Gauci, M.-L., Aristei, C., Becker, J. C., Blom, A., Bataille, V., Dreno, B., Del Marmol, V., Forsea, A. M., Fargnoli, M. C., Grob, J.-J., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.03.043 · Cited by 192
Delirium in adult cancer patients: ESMO Clinical Practice Guidelines
Bush, S. H., Lawlor, P. G., Ryan, K., Centeno, C., Lucchesi, M., Kanji, S., Siddiqi, N., Morandi, A., Davis, D. H. J., Laurent, M., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy147 · Cited by 190
Self-citationDelphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines
Cavestro, G. M., Mannucci, A., Balaguer, F., Hampel, H., Kupfer, S. S., Repici, A., Bianchi, A. S., Seppälä, T. T., Valentini, V., Boland, C. R., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.12.006 · Cited by 174
“231 Inadequate pain control contributes to poor quality of life and negative emotional status.”
Self-citationPeterson, D. E., Koyfman, S. A., Yarom, N., Lynggaard, C. D., Ismaila, N., Forner, L. E., Fuller, C. D., Mowery, Y. M., Murphy, B. A., Watson, E. E., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.23.02750 · Cited by 173
Mierzynska, J., Piccinin, C., Pe, M. L., Martinelli, F., Gotay, C. C., Coens, C., Mauer, M. E. L., Eggermont, A. M. M., Grøenvold, M., Bjordal, K., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30656-4 · Cited by 168
Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications
Pu, T., Sun, J., Ren, G., & Li, H. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02241-8 · Cited by 171
Updated Clinical Pharmacokinetics and Pharmacodynamics of Oxycodone
Kinnunen, M., Piirainen, P., Kokki, H. J., Lammi, P., & Kokki, M. (2019) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-00731-3 · Cited by 128
Management of breathlessness in patients with cancer: ESMO Clinical Practice Guidelines
Hui, D., Maddocks, M. M., Johnson, M. J., Ekström, M. P., Simon, S. T., Ogliari, A. C., Booth, S., & Ripamonti, C. I. (2020) · ESMO Open · doi:10.1136/esmoopen-2020-001038 · Cited by 143
Self-citationAman, M. M., Mahmoud, A., Deer, T. R., Sayed, D., Hagedorn, J. M., Brogan, S. E., Singh, V., Gulati, A., Strand, N. H., Weisbein, J. S., et al. (2021) · Journal of Pain Research · doi:10.2147/jpr.s315585 · Cited by 144
Practice review: Evidence-based and effective management of pain in patients with advanced cancer
Chapman, E., Edwards, Z., Boland, J. W., Maddocks, M. M., Fettes, L., Malia, C., Mulvey, M. R., & Bennett, M. (2020) · Palliative Medicine · doi:10.1177/0269216319896955 · Cited by 127
Pain Prevalence During Cancer Treatment: A Systematic Review and Meta-Analysis
Evenepoel, M., Haenen, V., Baerdemaecker, T. D., Meeus, M., Devoogdt, N., Dams, L., Dijck, S. V., der Gucht, E. V., & Groef, A. D. (2021) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2021.09.011 · Cited by 146
Cancer-Related Neuropathic Pain
Edwards, H. L., Mulvey, M. R., & Bennett, M. (2019) · Cancers · doi:10.3390/cancers11030373 · Cited by 113
Häuser, W., Welsch, P., Klose, P., Radbruch, L., & Fitzcharles, M. (2019) · Der Schmerz · doi:10.1007/s00482-019-0373-3 · Cited by 108
ESTRO ACROP guidelines for external beam radiotherapy of patients with complicated bone metastases
Oldenburger, E., Brown, S. L., Willmann, J., van der Velden, J. M., Spalek, M. J., van der Linden, Y. M., Kaźmierska, J., Menten, J. J., Andratschke, N. H., & Hoskin, P. (2022) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2022.06.002 · Cited by 96
“Neuropathic pain is defined by the International Association for the Study of Pain as ‘‘pain caused by a lesion or disease of the somatosensory nervous system” [60].”
BackgroundMethodSelf-citationPalliative care and end-of-life care in adults with malignant brain tumors
Koekkoek, J. A. F., van der Meer, P. B., Pace, A., Hertler, C., Harrison, R. A., Leeper, H. E., Forst, D. A., Jalali, R., Oliver, K. R., Philip, J. A. M., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac216 · Cited by 103
Enzinger, A., Ghosh, K., Keating, N., Cutler, D., Clark, C., Florez, N., Landrum, M., & Wright, A. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.01413 · Cited by 51
Lopes‐Júnior, L. C., Rosa, G. S., Pessanha, R. M., Schuab, S. I. P. D. C., Nunes, K. Z., & Amorim, M. H. C. (2020) · Revista Latino-Americana de Enfermagem · doi:10.1590/1518-8345.4213.3377 · Cited by 105
“Although the WHO Analgesic Scale has been widely used(6-7), approximately 40% to 50% of the cancer pain cases have inadequaterelief due to their multi-factorial nature(8).”
MethodAcupuncture for palliative cancer pain management: systematic review
Yang, J., Wahner‐Roedler, D. L., Zhou, X., Johnson, L. A., Do, A., Pachman, D. R., Chon, T. Y., Salinas, M. G., Millstine, D. M., & Bauer, B. A. (2021) · BMJ Supportive & Palliative Care · doi:10.1136/bmjspcare-2020-002638 · Cited by 99
Cryoablation for Palliation of Painful Bone Metastases: The MOTION Multicenter Study
Jennings, J. W., Prologo, J. D., Garnon, J., Gangi, A., Buy, X., Palussière, J., Kurup, A. N., Callstrom, M. R., Genshaft, S. J., Abtin, F. G., et al. (2021) · Radiology Imaging Cancer · doi:10.1148/rycan.2021200101 · Cited by 80
Intrathecal Drug Delivery: Advances and Applications in the Management of Chronic Pain Patient
Andrés, J. A. D., Hayek, S. M., Perruchoud, C., Lawrence, M. M., Reina, M. Á., Andrés-Serrano, C. D., Rubio-Haro, R., Hunt, M. A., & Yaksh, T. L. (2022) · Frontiers in Pain Research · doi:10.3389/fpain.2022.900566 · Cited by 86
Pain Management in Patients with Multiple Myeloma: An Update
Coluzzi, F., Rolke, R., & Mercadante, S. (2019) · Cancers · doi:10.3390/cancers11122037 · Cited by 73
Self-citationLiving systematic review to assess the analgesic undertreatment in cancer patients
Roberto, A., Greco, M. T., Uggeri, S., Cavuto, S., Deandrea, S., Corli, O., & Apolone, G. (2022) · Pain Practice · doi:10.1111/papr.13098 · Cited by 80
CACA Guidelines for Holistic Integrative Management of Breast Cancer
Wu, J., Fan, D., Shao, Z., Xu, B., Ren, G., Jiang, Z., Wang, Y., Jin, F., Zhang, J., Zhang, Q., et al. (2022) · Holistic Integrative Oncology · doi:10.1007/s44178-022-00007-8 · Cited by 121
Adrenocortical carcinoma: a practical guide for clinicians
Faßnacht, M., Puglisi, S., Kimpel, O., & Terzolo, M. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00378-4 · Cited by 96
Management of pain in colorectal cancer patients
Zielińska, A., Włodarczyk, M., Makaro, A., Sałaga, M., & Fichna, J. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103122 · Cited by 65
Opioid analgesics for nociceptive cancer pain: A comprehensive review
Shaheed, C. A., Hayes, C., Maher, C. G., Ballantyne, J. C., Underwood, M. R., McLachlan, A. J., Martin, J. H., Narayan, S. W., & Sidhom, M. A. (2023) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21823 · Cited by 108
“13 Dietary fiber There is limited evidence evaluating the effects of dietary fiber on improving OIC symptoms in people with cancer pain.”
BackgroundInfluentialColuzzi, F., Caputi, F. F., Billeci, D., Pastore, A. L., Candeletti, S., Rocco, M., & Romualdi, P. (2020) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s262843 · Cited by 75
de Almeida, A. S., Bernardes, L. D. B., & Trevisan, G. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174185 · Cited by 64
Ketamine as a therapeutic agent for depression and pain: mechanisms and evidence
Subramanian, S., Haroutounian, S., Palanca, B. J. A., & Lenze, E. J. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120152 · Cited by 76
Cancer Pain Management—New Therapies
Zhang, H. (2022) · Current Oncology Reports · doi:10.1007/s11912-021-01166-z · Cited by 74
From pain to tumor immunity: influence of peripheral sensory neurons in cancer
Mardelle, U., Bretaud, N., Daher, C., & Feuillet, V. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1335387 · Cited by 68
“Consequently, paracetamol and non-steroidal anti-in fl ammatory drugs (NSAIDs) are employed to address mild pain in patients, whereas mild and potent opioids such as codeine, tramadol, and morphine are utilized for the management of moderate to severe pain (61, 62).”
BackgroundSensors and Devices Guided by Artificial Intelligence for Personalized Pain Medicine
Xing, Y., Yang, K., Lu, A., Mackie, K., & Guo, F. (2024) · Cyborg and Bionic Systems · doi:10.34133/cbsystems.0160 · Cited by 78
Capsaicinoids: Multiple effects on angiogenesis, invasion and metastasis in human cancers
Friedman, J. R., Richbart, S. D., Merritt, J. C., Brown, K. C., Denning, K. L., Tirona, M. T., Valentovic, M. A., Miles, S. L., & Dasgupta, P. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109317 · Cited by 65
Mawatari, H., Shinjo, T., Morita, T., Kohara, H., & Yomiya, K. (2022) · Journal of Palliative Medicine · doi:10.1089/jpm.2021.0438 · Cited by 64
Neuropathic Pain in Cancer: What Are the Current Guidelines?
Mulvey, M. R., Paley, C. A., Schuberth, A., King, N., Page, A., & Neoh, K. (2024) · Current Treatment Options in Oncology · doi:10.1007/s11864-024-01248-7 · Cited by 71
“Initiating analgesic treatment of NCP with low dose strong opioids may achieve equivalent pain relief with fewer side effects, and may be more efficient, i.e. achieve pain relief quicker than weak opioids [33].”
BackgroundInfluentialMatsuoka, H., Iwase, S., Miyaji, T., Kawaguchi, T., Ariyoshi, K., Oyamada, S., Satomi, E., Ishiki, H., Hasuo, H., Sakuma, H., et al. (2019) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2019.06.020 · Cited by 61
Cuomo, A., Cascella, M., Forte, C. A., Bimonte, S., Esposito, G., Santis, S. D., Cavanna, L., Fusco, F., Dauri, M., Natoli, S., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041003 · Cited by 54
Treatment of Neuropathic Pain Directly Due to Cancer: An Update
Shkodra, M., & Caraceni, A. T. (2022) · Cancers · doi:10.3390/cancers14081992 · Cited by 59
Schepis, T., Lucia, S. S. D., Pellegrino, A., GAUDIO, A. D., Maresca, R., Coppola, G., Chiappetta, M. F., Gasbarrini, A., Franceschi, F., Candelli, M., et al. (2023) · Cancers · doi:10.3390/cancers15133423 · Cited by 59
The Effects of Auricular Therapy for Cancer Pain: A Systematic Review and Meta‐Analysis
Yang, Y., Wen, J., & Hong, J. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/1618767 · Cited by 51
“Introduction Pain is one of the most prevalent symptoms in cancer patients, when the prevalence is estimated to be more than 70% [1].”
BackgroundFallon, M., Dierberger, K., Leng, M. E. F., Hall, P. S., Allende, S., Sabar, R., Verástegui, E. L., Gordon, D., Grant, L., Lee, R., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.08.083 · Cited by 61
Self-citationFaggiano, A., Mazzilli, R., Natalicchio, A., Adinolfi, V., Argentiero, A., Danesi, R., D’Oronzo, S., Fogli, S., Gallo, M., Giuffrida, D., et al. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103826 · Cited by 62
“Dexamethasone should be prescribed in a dose of 8 – 16 mg i.v. daily tapered over two weeks (Fallon et al., 2018), considering the unclear benefits and the increased risk of serious AEs in ultra-high dose protocols (up to 96 – 100 mg/day) (Graham et al., 2006; George et al., 2015).”
BackgroundCancer pain: molecular mechanisms and management
Wang, W., Hao, Y.-H., Pang, X., & Tang, Y. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00289-0 · Cited by 66
Danon‐Hersch, N., Al‐Gobari, M., Burnand, B., & Rodondi, P. (2021) · Psycho-Oncology · doi:10.1002/pon.5821 · Cited by 63
Opioids drive breast cancer metastasis through the δ-opioid receptor and oncogenic STAT3
Tripolt, S., Neubauer, H. A., Knab, V. M., Elmer, D. P., Aberger, F., Moriggl, R., & Fux, D. A. (2021) · Neoplasia · doi:10.1016/j.neo.2020.12.011 · Cited by 52
Why and How to Integrate Early Palliative Care Into Cutting-Edge Personalized Cancer Care
Petrillo, L. A., Jones, K. F., El-Jawahri, A. R., Sanders, J. J., Greer, J. A., & Temel, J. S. (2024) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_100038 · Cited by 63
The Burden of Metastatic Cancer–Induced Bone Pain: A Narrative Review
Colosia, A. D., Njue, A., Bajwa, Z. H., Dragon, E., Robinson, R. L., Sheffield, K. M., Thakkar, S., & Richiemer, S. H. (2022) · Journal of Pain Research · doi:10.2147/jpr.s371337 · Cited by 51
“However, the evidence for an analgesic effect of bisphosphonates on bone pain is weak.(8) The analgesic effects of bisphosphonates are modest, so other medications are needed as the primary agent for pain relief.”
BackgroundInfluentialEmergency Department Visits for Opioid Overdoses Among Patients With Cancer
Jairam, V., Yang, D. X., Yu, J. B., & Park, H. S.-M. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz233 · Cited by 49
“related pain in adult patients (13,14), the optimal management of such symptoms can be challenging.”
BackgroundCancer induced bone pain: current management and future perspectives
Kapoor, R., Saxena, A. K., Vasudev, P., Sundriyal, D., & Kumar, A. (2021) · Medical Oncology · doi:10.1007/s12032-021-01587-7 · Cited by 46
“It can be used with an osteoclast inhibitor [19, 37].”
BackgroundMethodOpioid-Induced Constipation in Oncological Patients: New Strategies of Management
Mesı́a, R., Echaburu, J. A. V., Gómez, J., Saurí, T., Serrano, G., & Pujol, E. (2019) · Current Treatment Options in Oncology · doi:10.1007/s11864-019-0686-6 · Cited by 44
Management of pain in patients with bone metastases
Jing, D., Zhao, Q., Zhao, Y., Lu, X., Feng, Y., Zhao, B., & Zhao, X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1156618 · Cited by 47
“Although morphine and methadone show similar analgesic effects after single dose administration, it is recommended to reduce the anodynia dose by one quarter to one twelfth when switching from another opioid to methadone to prevent side effects such as respiratory depression (57).”
BackgroundConstipation in Cancer Patients — an Update of Clinical Evidence
Dzierżanowski, T., & Mercadante, S. (2022) · Current Treatment Options in Oncology · doi:10.1007/s11864-022-00976-y · Cited by 48
Opioids in cancer-related pain: current situation and outlook
George, B., Minello, C., Allano, G., Maindet, C., Burnod, A., & Lemaire, A. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-04828-8 · Cited by 49
Li, A., Shi, J., Bai, Y., Zhang, S., & Gan, J. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9615 · Cited by 39
Framework for opioid stigma in cancer pain
Bulls, H. W., Chu, E., Goodin, B. R., Liebschutz, J. M., Wozniak, A. J., Schenker, Y., & Merlin, J. S. (2021) · Pain · doi:10.1097/j.pain.0000000000002343 · Cited by 45
Opioid antagonists as potential therapeutics for ischemic stroke
Peyravian, N., Dikici, E., Deo, S. K., Toborek, M. J., & Daunert, S. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101679 · Cited by 40
Management of cancer pain due to bone metastasis
Takei, D., & Tagami, K. (2022) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-022-01382-y · Cited by 36
Gress, K. L., Charipova, K., Kaye, A. D., Viswanath, O., & Urits, I. (2020) · Oncology and Therapy · doi:10.1007/s40487-020-00128-y · Cited by 45
Liu, J., Wang, C., Chen, X., Luo, J., Xie, J., Li, S., Hu, J., & Shi, C. (2019) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2019.09.005 · Cited by 39
Pain management with opioids in adults
Montgomery, L. S. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24695 · Cited by 41
Antich-Isern, P., Caro-Barri, J., & Aparicio-Blanco, J. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120992 · Cited by 44
Kristoffersen, A. E., Wider, B., Nilsen, J. V., Bjelland, M., Mora, D. C., Nordberg, J. H., Broderstad, A. R., Nakandi, K., & Stub, T. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03790-z · Cited by 37
“Analgesic drugs are only one part of cancer pain management and a variety of non-invasive techniques such as psychological and rehabilitative interventions are recommended [47].”
BackgroundEffects of Opioids on Immune and Endocrine Function in Patients with Cancer Pain
Bradley, A., & Boland, J. W. (2023) · Current Treatment Options in Oncology · doi:10.1007/s11864-023-01091-2 · Cited by 32
Assessing cancer pain—the first step toward improving patients’ quality of life
Minello, C., George, B., Allano, G., Maindet, C., Burnod, A., & Lemaire, A. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-04825-x · Cited by 44
Ayoub, N. M., Jibreel, M., Nuseir, K. Q., & Al‐Taani, G. M. (2022) · International Journal of Clinical Practice · doi:10.1155/2022/1136430 · Cited by 30
“…the World Health Organization (WHO), the National Comprehensive Cancer Network (NCCN), [9] the European Association for Palliative Care (EAPC), [10] the European Society for Medical Oncology (ESMO), [11] and the American Society of Clinical Oncology (ASCO) clinical practice guidelines [12].”
Bulls, H. W., Hamm, M., Wasilko, R., Cameron, F. D. A., Belin, S. C., Goodin, B. R., Liebschutz, J. M., Wozniak, A. J., Sabik, L. M., Merlin, J. S., et al. (2022) · JCO Oncology Practice · doi:10.1200/op.22.00251 · Cited by 32
“RESULTS Patients and their support providers described three primary manifestations of opioid stigma: (1) direct experiences with opioid stigma and discrimination in health care settings (eg, negative, stigmatizing interactions in pharmacies or a pain clinic); (2) concerns about opioid stigma affecting patient care in…”
BackgroundInfluentialBreakthrough cancer pain: review and calls to action to improve its management
Camps, C., Batista, N., Fernández, N. D., Álvarez, Y. E., Gómez, A. G., Casado, D. I., Salud, A., Pons, J. T., & Porta, V. G. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02268-8 · Cited by 33
Cascella, M., Coluccia, S., Monaco, F., SCHIAVO, D., Nocerino, D., Grizzuti, M., Romano, M. C., & Cuomo, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11185484 · Cited by 31
Bibliometric Network Analysis on Rapid-Onset Opioids for Breakthrough Cancer Pain Treatment
Cascella, M., Monaco, F., Nocerino, D., Chinè, E., Carpenedo, R., Picerno, P., Migliaccio, L., Armignacco, A., Franceschini, G., Coluccia, S., et al. (2022) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2022.01.023 · Cited by 30
“For example, the European Society for Medical Oncology (ESMO) guidelines strongly recommend the use of ROOs (level of evidence I, degree of recommendation A).(6) On the contrary, the WHO guidelines indicated that BTcP should always be relieved with rescue drugs based on clinical experience and patient need, and recomm…”
BackgroundLi, Y., Ma, J., Lu, G.-J., Dou, Z., Knaggs, R., Xia, J., Zhao, S., Dong, S., & Yang, L. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011108.pub3 · Cited by 41
Valverde, C. P. T., Ebrahimi, G., Sprangers, M. A. G., Pateras, K., Bruynzeel, A. M. E., Jacobs, M., Wilmink, J. W., Besselink, M. G., Crezee, J., van Tienhoven, G., et al. (2023) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2023.08.055 · Cited by 28
Cannabinoids in Chronic Pain Management: A Review of the History, Efficacy, Applications, and Risks
Johnson, B. W., Strand, N. H., Raynak, J., Jara, C., Habtegiorgis, K., Hand, B. A., Hong, S., & Maloney, J. A. (2025) · Biomedicines · doi:10.3390/biomedicines13030530 · Cited by 36
“The European Society for Medical Oncology issued a grade D recommendation in its 2018 guidelines [80], citing insufficient or low-quality evidence to support cannabinoids for cancer-related pain.”
Schaller, A. S., Peterson, A., & Bäckryd, E. (2020) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2020-0067 · Cited by 32
Chan, K. Y., Chan, T. S. Y., Gill, H., Chan, T. C. W., Li, C. W., Au, H. Y., Wong, C. Y., Tsang, K. W., Lo, R. S. K., Cheng, H. W. B., et al. (2022) · Annals of Palliative Medicine · doi:10.21037/apm-22-691 · Cited by 35
Groef, A. D., Evenepoel, M., Dijck, S. V., Dams, L., Haenen, V., Wiles, L., Catley, M. J., Vogelzang, A. R., Olver, I., Hibbert, P. D., et al. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-022-07557-7 · Cited by 31
Ng, J. Y., & Sharma, A. E. (2020) · Pain Practice · doi:10.1111/papr.12964 · Cited by 26
Lin, R., Lin, S., Feng, S., Wu, Q., Fu, J., Wang, F., Li, H., Li, X., Zhang, G., Yao, Y., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.7699 · Cited by 27
“tools are warranted to screen patients and to monitor opioid consumption.(8,10) It is unsurprising that patient satisfaction with pain control was better in the PCA group, because PCA provides a greater degree of analgesic autonomy.”
BackgroundMethodPain associated with breast cancer: etiologies and therapies
Doan, L., Yoon, J., Chun, J., Perez, R. A., & Wang, J. (2023) · Frontiers in Pain Research · doi:10.3389/fpain.2023.1182488 · Cited by 44
Manabe, S., Miyano, K., Fujii, Y., Ohshima, K., Yoshida, Y., Nonaka, M., Uzu, M., MATSUOKA, Y., Sato, T., Uezono, Y., et al. (2019) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2019.06.005 · Cited by 28
Advances in pain management for older patients with cancer
Hachem, G. E., Rocha, F. O., Pepersack, T., Jounblat, Y., Drowart, A., & Lago, L. D. (2019) · ecancermedicalscience · doi:10.3332/ecancer.2019.980 · Cited by 33
Breakthrough cancer pain in 2020
Løhre, E. T., Thronæs, M., & Klepstad, P. (2020) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000494 · Cited by 28
“Today, a simple clinical algorithm for the diagnosis of BTCP is widely used, and it may serve as the basis for further development (3, 12).”
BackgroundMethodInfluentialCascella, M., Vittori, A., Petrucci, E., Marinangeli, F., Giarratano, A., Cacciagrano, C., Tizi, E. S., Miceli, L., Natoli, S., & Cuomo, A. (2022) · Healthcare · doi:10.3390/healthcare10030441 · Cited by 26
Treatment Algorithm for Cancerous Wounds: A Systematic Review
Furka, A., Simkó, C., Kostyál, L. Á., Szabó, I., Valikovics, A. K., Fekete, G., Tornyi, I., Oross, E., & Révész, J. (2022) · Cancers · doi:10.3390/cancers14051203 · Cited by 26
“• Interventional treatments: intrathecal drug administration (opioids, local anesthetics, ziconotide, baclofen, clonidin) may be necessary in a small percentage of patients who are unresponsive to conventional therapies [33].”
BackgroundKistemaker, K. R. J., Sijani, F., Brinkman, D. J., de Graeff, A., Burchell, G. L., Steegers, M. A. H., & van Zuylen, L. (2024) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2024.102704 · Cited by 25
Metadata
- Authors
- Fallon, M., Giusti, R., Aielli, F., Hoskin, P., Rolke, R., Sharma, M., & Ripamonti, C. I.
- Affiliations
- Edinburgh Cancer Research (GB)
- Azienda Ospedaliera Sant'Andrea (IT)
- University of L'Aquila (IT)
- Mount Vernon Cancer Centre (GB)
- RWTH Aachen University (DE)
- Walton Centre (GB)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 29
- Issue
- Suppl 4
- Pages
- iv166-iv191
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2834719472
- Cited by
- 954
- References
- 184
- Citations by year
- 2026: 136 · 2025: 140 · 2024: 143 · 2023: 123 · 2022: 129 · 2021: 126 · 2020: 88 · 2019: 61 · 2018: 6
- FWCI
- 103.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 463 d)
- Locations
- Annals of Oncology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion, other-oa)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Funders
- Marie Curie (MCCC-RP-12-A14197, MCCC-RP-15-A18862, MCCC-RP-15-A19005)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pediatric Pain Management Techniques
- Keywords
- cancer pain, pain management, advanced cancer, metastatic cancer, terminal cancer, pain prevalence, palliative care, analgesia
- MeSH terms
- Cancer Pain, Cancer Survivors, Pain, Procedural, Procedural Pain, Adult, Analgesics, Opioid, Antineoplastic Combined Chemotherapy Protocols, Europe, Humans, Medical Oncology, Neoplasm Staging, Neoplasms, Pain Measurement, Societies, Medical, Terminal Care, Prevalence, Treatment Outcome, Breakthrough Pain, Pain Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.